The largest database of trusted experimental protocols

M mlv reverse transcriptase reagent

Manufactured by Promega
Sourced in United States

M-MLV Reverse Transcriptase is a recombinant enzyme that catalyzes the conversion of RNA into complementary DNA (cDNA) during reverse transcription. It is a key component in the synthesis of cDNA for various applications such as gene expression analysis and cDNA library construction.

Automatically generated - may contain errors

4 protocols using m mlv reverse transcriptase reagent

1

Quantitative RNA Analysis in Drosophila

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA was purified from 10 flies per each genotype (five males and five females) using Trizol Reagent, according to the manufacturer’s instructions (Thermo Fisher Scientific). cDNA was prepared from DNase I-treated RNA samples using the M-MLV Reverse Transcriptase reagent (Promega) and random hexamers. Diluted cDNA samples were quantitatively analyzed by SYBR Green-based Prime Q-Mastermix (GeNet Bio) and gene-specific primers using the LightCycler 480 real-time PCR system (Roche). To validate the efficiency of transgenic RNA interference, total RNAs from head or body extracts were analyzed similarly.
+ Open protocol
+ Expand
2

Quantifying LINC00467 and NF-kB-p65 Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA was extracted from the cells using TRIzol (Invitrogen), and the purity of the RNA was assessed spectrophotometrically (A260/A280>1.8). Approximately 1μg of total RNA was reverse transcribed into cDNA using an MMLV reverse transcriptase reagent (Promega, Madison, WI, USA). According to the manufacturer’s instructions, real-time qRT-PCR was used to detect LINC00467 and NF-kb-p65 mRNA expression using a SYBR Green PCR Master Mix on an ABI 7500 sequence detection system (Life Technologies). All experiments were performed in triplicate using β-actin or U1 as internal controls. Relative expression levels were calculated using the 2-ΔΔCt method. The following primer sequences were used: LINC00467-F: 5-TCGTCTTCAGGAAGCCAGAC-3; R: 5- TGGAAATCAAAAGGGTCAGC-3; NF-kb-p65 -F: 5-ATGTGGAGATCATTGAGCAGC-3; R: 5-CCTGGTCCTGTGTAGCCATT-3; β-actin -F: 5-CATGTACGTTGCTA TCCAGGC-3; R: 5-CTCCTTAATGTCACGCACGAT-3; U1 -F: 5- GGGAGATACCATGATCACGAAGGT-3; R: 5- CCACAAATTATGCAGTCGAGTTTCCC-3.
+ Open protocol
+ Expand
3

miRNA Expression Analysis Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
The RNAs were extracted via an Rneasy Mini kit (Qiagen, Inc., Valencia, CA, USA). Then, reverse transcription experiments were conducted on the RNAs through the usage of miRNA cDNA Synthesis reagent (Vazyme, Nanjing, China) or M-MLV Reverse Transcriptase reagent (Promega, Madison, WI, USA) in line with the protocols. Next, qRT-PCR was manipulated by using SYBR Green qPCR mix (Takara, Dalian, China). The 2−ΔΔCt method was employed to compute the expression. GAPDH and U6 served as internal controls. The primers used are exhibited in Table 1.
+ Open protocol
+ Expand
4

Quantitative Analysis of RNA Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
RNA isolation was manipulated with RNAiso Plus (Takara, Dalian, China). Then M-MLV Reverse Transcriptase reagent (Promega, Madison, WI, United States) or All-in-One™ miRNA Detection reagent (GeneCopoeia, FulenGen, China) was employed on total RNA for the synthesis of cDNAs. Afterward, SYBR Green qPCR mix (Takara) was used for the reaction on an ABI 7500 Real-Time PCR system (Applied Biosystems, Foster City, CA, United States). The expression was computed by the 2−ΔΔCt way. β-actin and U6 served as the internal controls. The primers were listed in Table 1.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!